Heartbeam Inc

NASDAQ BEAT

Download Data

Heartbeam Inc EBITDA Ratio for the quarter ending March 31, 2024

Heartbeam Inc EBITDA Ratio is NA for the quarter ending March 31, 2024. EBITDA Ratio is the ratio of EBITDA to revenue, indicating the operating profitability and efficiency of a company.
  • Heartbeam Inc EBITDA Ratio for the quarter ending March 31, 2020 was 22.05%, a 3.68% change year over year.
NASDAQ: BEAT

Heartbeam Inc

CEO Mr. Richard M. Ferrari
IPO Date Nov. 11, 2021
Location United States
Headquarters 2118 Walsh Avenue, Santa Clara, CA, United States, 95050
Employees 15
Sector Healthcare
Industry Health information services
Description

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

StockViz Staff

September 16, 2024

Any question? Send us an email